BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

819 related articles for article (PubMed ID: 17344940)

  • 1. Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity.
    Kumar P; Padi SS; Naidu PS; Kumar A
    Methods Find Exp Clin Pharmacol; 2007; 29(1):19-25. PubMed ID: 17344940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms.
    Kumar P; Padi SS; Naidu PS; Kumar A
    Fundam Clin Pharmacol; 2007 Jun; 21(3):297-306. PubMed ID: 17521299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms.
    Bhateja DK; Dhull DK; Gill A; Sidhu A; Sharma S; Reddy BV; Padi SS
    Eur J Pharmacol; 2012 Jan; 674(1):33-43. PubMed ID: 22056833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of quercetin against ICV colchicine-induced cognitive dysfunctions and oxidative damage in rats.
    Kumar A; Sehgal N; Kumar P; Padi SS; Naidu PS
    Phytother Res; 2008 Dec; 22(12):1563-9. PubMed ID: 18980205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity.
    Ahuja M; Bishnoi M; Chopra K
    Toxicology; 2008 Feb; 244(2-3):111-22. PubMed ID: 18164115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible nitric oxide modulation in protective effect of (Curcuma longa, Zingiberaceae) against sleep deprivation-induced behavioral alterations and oxidative damage in mice.
    Kumar A; Singh A
    Phytomedicine; 2008 Aug; 15(8):577-86. PubMed ID: 18586477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine-induced dysfunction and oxidative stress in rats.
    Kumar A; Seghal N; Padi SV; Naidu PS
    Eur J Pharmacol; 2006 Dec; 551(1-3):58-66. PubMed ID: 17027965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine A attenuates 3-nitropropionic acid-induced Huntington-like symptoms in rats: possible nitric oxide mechanism.
    Kumar P; Kalonia H; Kumar A
    Int J Toxicol; 2010; 29(3):318-25. PubMed ID: 20448265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of curcumin on colchicine-induced cognitive dysfunction and oxidative stress in rats.
    Khurana S; Jain S; Mediratta PK; Banerjee BD; Sharma KK
    Hum Exp Toxicol; 2012 Jul; 31(7):686-97. PubMed ID: 22262262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine.
    Silva-Adaya D; Pérez-De La Cruz V; Herrera-Mundo MN; Mendoza-Macedo K; Villeda-Hernández J; Binienda Z; Ali SF; Santamaría A
    J Neurochem; 2008 May; 105(3):677-89. PubMed ID: 18194214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of sesamol against 3-nitropropionic acid-induced cognitive dysfunction and altered glutathione redox balance in rats.
    Kumar P; Kalonia H; Kumar A
    Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):577-82. PubMed ID: 20102363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
    Kumar P; Kumar A
    Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
    Kumar P; Kumar A
    J Med Food; 2009 Jun; 12(3):591-600. PubMed ID: 19627208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective role of sertraline against 3-nitropropionic acid-induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain.
    Kumar P; Kumar A
    Indian J Exp Biol; 2009 Sep; 47(9):715-22. PubMed ID: 19957883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trolox ameliorates 3-nitropropionic acid-induced neurotoxicity in rats.
    Al Mutairy A; Al Kadasah S; Elfaki I; Arshaduddin M; Malik D; Al Moutaery K; Tariq M
    Neurotoxicol Teratol; 2010; 32(2):226-33. PubMed ID: 19755148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin ameliorates cognitive dysfunction and oxidative damage in phenobarbitone and carbamazepine administered rats.
    Reeta KH; Mehla J; Gupta YK
    Eur J Pharmacol; 2010 Oct; 644(1-3):106-12. PubMed ID: 20667451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of the polyphenolic antioxidant agent, Curcumin, against homocysteine-induced cognitive impairment and oxidative stress in the rat.
    Ataie A; Sabetkasaei M; Haghparast A; Moghaddam AH; Kazeminejad B
    Pharmacol Biochem Behav; 2010 Oct; 96(4):378-85. PubMed ID: 20619287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
    Dhir A; Akula KK; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):835-43. PubMed ID: 18234412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype.
    Tadros MG; Khalifa AE; Abdel-Naim AB; Arafa HM
    Pharmacol Biochem Behav; 2005 Nov; 82(3):574-82. PubMed ID: 16337998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.